Edition:
United States

Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

9.50SEK
8 Dec 2016
Change (% chg)

0.10kr (+1.06%)
Prev Close
9.40kr
Open
9.55kr
Day's High
9.55kr
Day's Low
9.20kr
Volume
50,370
Avg. Vol
66,083
52-wk High
15.93kr
52-wk Low
7.37kr

Summary

Name Age Since Current Position

Mats Arnhog

65 2003 Chairman of the Board

Tomas Leanderson

60 2008 Chief Executive Officer, President

Hans Kolam

65 Chief Financial Officer

Helen Tuvesson

54 2011 Chief Scientific Officer

Magnhild Sandberg-Wollheim

79 2007 Independent Director

Peter Sjostrand

70 2000 Independent Director

Peter Thelin

60 2011 Independent Director

Biographies

Name Description

Mats Arnhog

Mr. Mats Arnhog has been Chairman of the Board of Directors of Active Biotech AB since 2003. He has been Member of the Company’s Board since 2000. He also serves as Member of the Active Biotech’s Election Committee. Mr. Arnhog chairs the Boards of Directors of MGA Holding AB, Psoriasis + Creams Sweden AB and Rederi AB Sea-Link. He is also Board Member of Ideella Foreningen Prima Gruppen, and serves as Member of Advisory Board of the Stockholm School of Economics (Handelshogskolan i Stockholm). Mr. Arnhog holds Master of Science degree and Honorary Doctorate of Philosophy degree in Economics from Handelshogskolan i Stockholm.

Tomas Leanderson

Mr. Tomas Leanderson has been President and Chief Executive Officer of Active Biotech AB since September 1, 2008. He was previously Chief Scientific Officer at the Company. He has been employed at Active Biotech since 1999. He has held a number of academic research positions both in Sweden and internationally. He is Doctor of Medical Science from Umea universitet.

Hans Kolam

Mr. Hans Kolam serves as Chief Financial Officer of Active Biotech AB. He has worked for the Company since 2000. He has over 35 years of experience within the pharmaceuticals industry, having held different positions at Pharmacia. He holds Master of Science degree in Economics from Uppsala Universitet.

Helen Tuvesson

Ms. Helen Tuvesson has served as Chief Scientific Officer at Active Biotech AB since April 1, 2011. She was previously Head of Preclinical Development at the Company until April 1, 2011. Ms. Tuvesson has been employed at Active Biotech AB since 1998. She has worked in the pharmaceutical industry for almost 20 years and has held various positions at Pharmacia. She is Doctor of Cellular and Molecular Biology from Lunds universitet.

Magnhild Sandberg-Wollheim

Ms. Magnhild Sandberg-Wollheim has served as Independent Member of the Board of Directors of Active Biotech AB since 2007. She is Associate Professor of Neurology and Consultant at the neurological clinic at Skane University Hospital. She is also Member of the Boards of Directors of MS-konsulten AB and Parkinson Research Foundation.

Peter Sjostrand

Dr. Peter Sjostrand. M.D. has served as Independent Member of the Board of Directors of Active Biotech AB since 2000. He is Chairman of the Boards of Directors of Byggnads AB S:t Erik, Ringens Varv ABand Stiftelsen Oscar Hirschs Minne (Oscar Hirsch’s Memory Foundation). Apart from this he serves as Member of the Boards of Directors of Peter Sjostrand AB, SAMF Sweden AB and assignments in the Acturum Group. He is also Member of the Strategic Council of School of Technology and Health (Kungliga Tekniska Hogskolan) and Vatera Holding Advisory Board. Mr. Sjostrand holds Master of Science degree from Handelshogskolan i Stockholm as well as Medical degree from Karolinska Institutet in Stockholm.

Peter Thelin

Mr. Peter Thelin has served as Independent Member of the Board of Directors of Active Biotech AB since May 5, 2011. He is also Member of the Boards at Brummer & Partners AB, ELC Fastigheter AB, East Bay AB, Sjunda Gard AB, Carve Intressenter AB, Sjuenda Holding AB, Psoriasis + Creams Sweden AB, Jarna mejeri AB and Rebellion Oil AB. He graduated from Handelshogskolan i Stockholm.

Basic Compensation

Name Fiscal Year Total

Mats Arnhog

250,000

Tomas Leanderson

6,105,000

Hans Kolam

--

Helen Tuvesson

--

Magnhild Sandberg-Wollheim

125,000

Peter Sjostrand

125,000

Peter Thelin

125,000
As Of  30 Dec 2015